K010668

Substantially Equivalent

BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY

Applicant: Bayer Corp.
Product code: LFX
Advisory panel: Microbiology
Date received: 2001-03-06
Decision date: 2001-07-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.